Positron Emission Tomography in the Neuroimaging of Autism Spectrum Disorder: A Review

Autism spectrum disorder (ASD) is a basket term for neurodevelopmental disorders characterized by marked impairments in social interactions, repetitive and stereotypical behaviors, and restricted interests and activities. Subtypes include (A) disorders with known genetic abnormalities including frag...

Full description

Bibliographic Details
Main Authors: Zhiqiang Tan, Huiyi Wei, Xiubao Song, Wangxiang Mai, Jiajian Yan, Weijian Ye, Xueying Ling, Lu Hou, Shaojuan Zhang, Sen Yan, Hao Xu, Lu Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnins.2022.806876/full
_version_ 1811309781449703424
author Zhiqiang Tan
Huiyi Wei
Xiubao Song
Wangxiang Mai
Jiajian Yan
Weijian Ye
Xueying Ling
Lu Hou
Shaojuan Zhang
Sen Yan
Hao Xu
Lu Wang
author_facet Zhiqiang Tan
Huiyi Wei
Xiubao Song
Wangxiang Mai
Jiajian Yan
Weijian Ye
Xueying Ling
Lu Hou
Shaojuan Zhang
Sen Yan
Hao Xu
Lu Wang
author_sort Zhiqiang Tan
collection DOAJ
description Autism spectrum disorder (ASD) is a basket term for neurodevelopmental disorders characterized by marked impairments in social interactions, repetitive and stereotypical behaviors, and restricted interests and activities. Subtypes include (A) disorders with known genetic abnormalities including fragile X syndrome, Rett syndrome, and tuberous sclerosis and (B) idiopathic ASD, conditions with unknown etiologies. Positron emission tomography (PET) is a molecular imaging technology that can be utilized in vivo for dynamic and quantitative research, and is a valuable tool for exploring pathophysiological mechanisms, evaluating therapeutic efficacy, and accelerating drug development in ASD. Recently, several imaging studies on ASD have been published and physiological changes during ASD progression was disclosed by PET. This paper reviews the specific radioligands for PET imaging of critical biomarkers in ASD, and summarizes and discusses the similar and different discoveries in outcomes of previous studies. It is of great importance to identify general physiological changes in cerebral glucose metabolism, cerebral blood flow perfusion, abnormalities in neurotransmitter systems, and inflammation in the central nervous system in ASD, which may provide excellent points for further ASD research.
first_indexed 2024-04-13T09:47:12Z
format Article
id doaj.art-07a3e4117dcf494faf154fefde138765
institution Directory Open Access Journal
issn 1662-453X
language English
last_indexed 2024-04-13T09:47:12Z
publishDate 2022-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neuroscience
spelling doaj.art-07a3e4117dcf494faf154fefde1387652022-12-22T02:51:42ZengFrontiers Media S.A.Frontiers in Neuroscience1662-453X2022-04-011610.3389/fnins.2022.806876806876Positron Emission Tomography in the Neuroimaging of Autism Spectrum Disorder: A ReviewZhiqiang Tan0Huiyi Wei1Xiubao Song2Wangxiang Mai3Jiajian Yan4Weijian Ye5Xueying Ling6Lu Hou7Shaojuan Zhang8Sen Yan9Hao Xu10Lu Wang11Center of Cyclotron and PET Radiopharmaceuticals, Department of Nuclear Medicine and PET/CT-MRI Center, The First Affiliated Hospital of Jinan University, Guangzhou, ChinaCenter of Cyclotron and PET Radiopharmaceuticals, Department of Nuclear Medicine and PET/CT-MRI Center, The First Affiliated Hospital of Jinan University, Guangzhou, ChinaDepartment of Rehabilitation Medicine, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, ChinaDepartment of Rehabilitation Medicine, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, ChinaDepartment of Rehabilitation Medicine, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, ChinaCenter of Cyclotron and PET Radiopharmaceuticals, Department of Nuclear Medicine and PET/CT-MRI Center, The First Affiliated Hospital of Jinan University, Guangzhou, ChinaCenter of Cyclotron and PET Radiopharmaceuticals, Department of Nuclear Medicine and PET/CT-MRI Center, The First Affiliated Hospital of Jinan University, Guangzhou, ChinaCenter of Cyclotron and PET Radiopharmaceuticals, Department of Nuclear Medicine and PET/CT-MRI Center, The First Affiliated Hospital of Jinan University, Guangzhou, ChinaCenter of Cyclotron and PET Radiopharmaceuticals, Department of Nuclear Medicine and PET/CT-MRI Center, The First Affiliated Hospital of Jinan University, Guangzhou, ChinaGuangdong-Hongkong-Macau Institute of CNS Regeneration, Ministry of Education CNS Regeneration Collaborative Joint Laboratory, Jinan University, Guangzhou, ChinaCenter of Cyclotron and PET Radiopharmaceuticals, Department of Nuclear Medicine and PET/CT-MRI Center, The First Affiliated Hospital of Jinan University, Guangzhou, ChinaCenter of Cyclotron and PET Radiopharmaceuticals, Department of Nuclear Medicine and PET/CT-MRI Center, The First Affiliated Hospital of Jinan University, Guangzhou, ChinaAutism spectrum disorder (ASD) is a basket term for neurodevelopmental disorders characterized by marked impairments in social interactions, repetitive and stereotypical behaviors, and restricted interests and activities. Subtypes include (A) disorders with known genetic abnormalities including fragile X syndrome, Rett syndrome, and tuberous sclerosis and (B) idiopathic ASD, conditions with unknown etiologies. Positron emission tomography (PET) is a molecular imaging technology that can be utilized in vivo for dynamic and quantitative research, and is a valuable tool for exploring pathophysiological mechanisms, evaluating therapeutic efficacy, and accelerating drug development in ASD. Recently, several imaging studies on ASD have been published and physiological changes during ASD progression was disclosed by PET. This paper reviews the specific radioligands for PET imaging of critical biomarkers in ASD, and summarizes and discusses the similar and different discoveries in outcomes of previous studies. It is of great importance to identify general physiological changes in cerebral glucose metabolism, cerebral blood flow perfusion, abnormalities in neurotransmitter systems, and inflammation in the central nervous system in ASD, which may provide excellent points for further ASD research.https://www.frontiersin.org/articles/10.3389/fnins.2022.806876/fullautism spectrum disorderASDneuroimagingpositron emission tomographyPETradioligands
spellingShingle Zhiqiang Tan
Huiyi Wei
Xiubao Song
Wangxiang Mai
Jiajian Yan
Weijian Ye
Xueying Ling
Lu Hou
Shaojuan Zhang
Sen Yan
Hao Xu
Lu Wang
Positron Emission Tomography in the Neuroimaging of Autism Spectrum Disorder: A Review
Frontiers in Neuroscience
autism spectrum disorder
ASD
neuroimaging
positron emission tomography
PET
radioligands
title Positron Emission Tomography in the Neuroimaging of Autism Spectrum Disorder: A Review
title_full Positron Emission Tomography in the Neuroimaging of Autism Spectrum Disorder: A Review
title_fullStr Positron Emission Tomography in the Neuroimaging of Autism Spectrum Disorder: A Review
title_full_unstemmed Positron Emission Tomography in the Neuroimaging of Autism Spectrum Disorder: A Review
title_short Positron Emission Tomography in the Neuroimaging of Autism Spectrum Disorder: A Review
title_sort positron emission tomography in the neuroimaging of autism spectrum disorder a review
topic autism spectrum disorder
ASD
neuroimaging
positron emission tomography
PET
radioligands
url https://www.frontiersin.org/articles/10.3389/fnins.2022.806876/full
work_keys_str_mv AT zhiqiangtan positronemissiontomographyintheneuroimagingofautismspectrumdisorderareview
AT huiyiwei positronemissiontomographyintheneuroimagingofautismspectrumdisorderareview
AT xiubaosong positronemissiontomographyintheneuroimagingofautismspectrumdisorderareview
AT wangxiangmai positronemissiontomographyintheneuroimagingofautismspectrumdisorderareview
AT jiajianyan positronemissiontomographyintheneuroimagingofautismspectrumdisorderareview
AT weijianye positronemissiontomographyintheneuroimagingofautismspectrumdisorderareview
AT xueyingling positronemissiontomographyintheneuroimagingofautismspectrumdisorderareview
AT luhou positronemissiontomographyintheneuroimagingofautismspectrumdisorderareview
AT shaojuanzhang positronemissiontomographyintheneuroimagingofautismspectrumdisorderareview
AT senyan positronemissiontomographyintheneuroimagingofautismspectrumdisorderareview
AT haoxu positronemissiontomographyintheneuroimagingofautismspectrumdisorderareview
AT luwang positronemissiontomographyintheneuroimagingofautismspectrumdisorderareview